HRTX
Price
$2.60
Change
-$0.02 (-0.76%)
Updated
Feb 23, 6:59 PM EST
4 days until earnings call
ORMP
Price
$3.46
Change
+$0.16 (+4.85%)
Updated
Feb 23, 6:59 PM EST
5 days until earnings call
Ad is loading...

Compare predictions HRTX vs ORMP

Header iconHRTX vs ORMP Comparison
Open Charts HRTX vs ORMPBanner chart's image
Heron Therapeutics
Price$2.60
Change-$0.02 (-0.76%)
Volume$896.56K
CapitalizationN/A
Oramed Pharmaceuticals
Price$3.46
Change+$0.16 (+4.85%)
Volume$205.12K
CapitalizationN/A
View a ticker or compare two or three
HRTX vs ORMP Comparison Chart

Loading...

HRTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ORMPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
HRTX vs. ORMP commentary
Feb 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Sell and ORMP is a Buy.

COMPARISON
Comparison
Feb 24, 2024
Stock price -- (HRTX: $2.60 vs. ORMP: $3.46)
Brand notoriety: HRTX and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 29% vs. ORMP: 105%
Market capitalization -- HRTX: $393.19M vs. ORMP: $133.12M
HRTX [@Biotechnology] is valued at $393.19M. ORMP’s [@Biotechnology] market capitalization is $133.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $538.15B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 4 bullish TA indicator(s).

  • HRTX’s TA Score: 3 bullish, 5 bearish.
  • ORMP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than HRTX.

Price Growth

HRTX (@Biotechnology) experienced а -9.41% price change this week, while ORMP (@Biotechnology) price change was +10.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +18.40%, and the average quarterly price growth was +39.22%.

Reported Earning Dates

HRTX is expected to report earnings on May 09, 2024.

ORMP is expected to report earnings on May 29, 2024.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for HRTX with price predictions.
OPEN
A.I.dvisor published
a Summary for ORMP with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HRTX($391M) has a higher market cap than ORMP($140M). HRTX YTD gains are higher at: 52.941 vs. ORMP (49.784). ORMP has higher annual earnings (EBITDA): -15.96M vs. HRTX (-122.67M). ORMP has more cash in the bank: 175M vs. HRTX (77.4M). ORMP has less debt than HRTX: ORMP (76M) vs HRTX (180M). HRTX has higher revenues than ORMP: HRTX (123M) vs ORMP (2.02M).
HRTXORMPHRTX / ORMP
Capitalization391M140M279%
EBITDA-122.67M-15.96M769%
Gain YTD52.94149.784106%
P/E RatioN/AN/A-
Revenue123M2.02M6,086%
Total Cash77.4M175M44%
Total Debt180M76M237%
FUNDAMENTALS RATINGS
HRTX vs ORMP: Fundamental Ratings
HRTX
ORMP
OUTLOOK RATING
1..100
9450
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
40
Fair valued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (40) in the Pharmaceuticals Other industry is in the same range as HRTX (68) in the Biotechnology industry. This means that ORMP’s stock grew similarly to HRTX’s over the last 12 months.

ORMP's Profit vs Risk Rating (97) in the Pharmaceuticals Other industry is in the same range as HRTX (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to HRTX’s over the last 12 months.

ORMP's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as HRTX (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to HRTX’s over the last 12 months.

ORMP's Price Growth Rating (50) in the Pharmaceuticals Other industry is in the same range as HRTX (50) in the Biotechnology industry. This means that ORMP’s stock grew similarly to HRTX’s over the last 12 months.

ORMP's P/E Growth Rating (100) in the Pharmaceuticals Other industry is in the same range as HRTX (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to HRTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HRTXORMP
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 19 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
N/A
View a ticker or compare two or three
Ad is loading...
HRTXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ORMPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDETX21.79N/A
N/A
Fidelity Advisor Capital Development O
BMCRX25.03N/A
N/A
BlackRock Advantage Large Cap Gr R
LSVQX17.69N/A
N/A
LSV Small Cap Value Institutional
MXOAX10.05N/A
N/A
Empower Ariel Mid Cap Value Instl
IGOAX10.36N/A
N/A
Rational Real Assets Fund Class A

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with MDGL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-0.76%
MDGL - HRTX
49%
Loosely correlated
-4.82%
AMRN - HRTX
44%
Loosely correlated
+0.85%
ORMP - HRTX
43%
Loosely correlated
+4.85%
CRSP - HRTX
41%
Loosely correlated
-2.55%
NTLA - HRTX
39%
Loosely correlated
-3.97%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with SRNEQ. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then SRNEQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
+4.85%
SRNEQ - ORMP
51%
Loosely correlated
N/A
KRYS - ORMP
48%
Loosely correlated
-0.55%
VXRT - ORMP
48%
Loosely correlated
-8.96%
MORF - ORMP
46%
Loosely correlated
-1.64%
ARCT - ORMP
45%
Loosely correlated
-0.05%
More